Effect of first ventricular tachycardia cycle length on rate of ventricular arrhythmia recurrence in patients with implantable cardioverter-defibrillator

Journal of Electrocardiology

Volumn 39, Issue 4, 2006, Pages 404-408

  Arya, Arash ^a   Haghjoo, Majid ^a   Nikoo, Mohammad Hosein ^a   Dehghani, Mohammad Reza ^a   Fazelifar, Amir Farjam ^a   Sadr Ameli, Mohammad Ali ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Implantable cardioverter defibrillator; Left ventricular ejection fraction; Sudden cardiac death; Ventricular tachycardia

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DEFIBRILLATOR; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE AND RHYTHM; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; QRS COMPLEX; SUDDEN DEATH; TIME SERIES ANALYSIS;

COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HUMANS; MIDDLE AGED; RECURRENCE; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 33749160518     PISSN: 00220736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jelectrocard.2005.11.003     Document Type: Article

References (13)

1. Priori S.G., Aliot E., Blomstrom-Lundqvist C., et al. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J 22 (2001) 1374
2. Ezekowitz J.A., Armstrong P.W., and McAlister A. Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med 138 (2003) 445
3. Gregoratos G., Abrams J., Epstein A.E., et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines American College of Cardiology/American Heart Association/North American Society for Pacing and Electrophysiology Committee. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 106 (2002) 2145
4. Arya A., Haghjoo M., and Sadr-Ameli M.A. Can amiodarone prevent sudden cardiac death in patients with hemodynamically tolerated sustained ventricular tachycardia and coronary artery disease?. Cardiovasc Drugs Ther 19 (2005) 219
5. Freedberg N.A., Hill J.N., Fogel R.I., and Prystowsky E.N. Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy. J Am Coll Cardiol 37 (2001) 1910
6. Raitt M.H., Renfroe E.G., Epstein A.E., et al. "Stable" ventricular tachycardia is not a benign rhythm: insights from the Antiarrhythmics Versus Implantable Defibrillators (AVID) registry. Circulation 103 (2001) 244
7. Schläpfer J., Rapp F., Kappenberger L., and Fromer M. Electrophysiologically guided amiodarone therapy versus the implantable cardioverter-defibrillator for sustained ventricular tachyarrhythmias after myocardial infarction results of long-term follow-up. J Am Coll Cardiol 39 (2002) 1813
8. Sarter B.H., Finkle J.K., Gerszten R.E., and Buxton A.E. What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after myocardial infarction?. J Am Coll Cardiol 28 (1996) 122
9. Olson P.J., Woelfel A., Simpson R.J., and Foster J.R. Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation. Am J Cardiol 71 (1993) 823
10. Bocker D., Block M., Isbruch F., et al. Benefits of treatment with implantable cardioverter-defibrillators in patients with stable ventricular tachycardia without cardiac arrest. Br Heart J 73 (1995) 158
11. Raitt M.H., Dolack G.L., Kudenchuk P.J., Poole J.E., and Bardy G.H. Ventricular arrhythmias detected after transvenous defibrillator implantation in patients with a clinical history of only ventricular fibrillation implications for use of implantable defibrillator. Circulation 91 (1995) 1996
12. Korte T., Köditz H., Niehaus M., Paul T., and Tebbenjuhanns J. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Pacing Clin Electrophysiol 27 (2004) 924
13. Sadoul N., Mletzko R., Anselme F., et al., for the Slow VT Study Group. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients an international multicenter prospective study. Circulation 112 (2005) 946